Amrutanjan reported FY26 operating profit growth of 34% and revenue growth of 11%, driven by strong performance in Pain Management and Women's Hygiene segments.
The company launched new products including razors, antiseptic plaster, ortho pain oil, and nasal spray, expanding into personal care categories.
Management outlined a positive outlook but flagged COGS inflation risks from Middle East wars affecting crude prices and supply chains.
Exceptional items of ₹8.85 crore were recorded for a legal lease rent provision and incremental labour code impact.